The Histamine H3receptor: An Attractive Target for the Treatment of Cognitive Disorders

British Journal of Pharmacology - United States
doi 10.1038/bjp.2008.147
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Review Article: Is WNT Signaling an Attractive Target for the Treatment of Osteoarthritis?

Rheumatology and Therapy
2020English

The Evidence for Histamine H3receptor-Mediated Endothelium-Dependent Relaxation in Isolated Rat Aorta

Mediators of Inflammation
ImmunologyCell Biology
1995English

The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2019English

The TGF-β1 Signaling Pathway as an Attractive Target in the Fibrosis Pathogenesis of Sjögren’s Syndrome

Mediators of Inflammation
ImmunologyCell Biology
2018English

Cognitive-Behavioral Treatment for Insomnia Comorbid With Psychiatric Disorders

Journal of Sleep Disorders & Therapy
2012English

A Meta-Analysis of Computerized Cognitive-Behavioral Therapy for the Treatment ofDSM-5Anxiety Disorders

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2014English

The “Rectosigmoid Brake”: Review of an Emerging Neuromodulation Target for Colorectal Functional Disorders

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2017English

FXR an Emerging Therapeutic Target for the Treatment of Atherosclerosis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2009English

Janus Kinases: An Ideal Target for the Treatment of Autoimmune Diseases

Journal of Investigative Dermatology Symposium Proceedings
DermatologyMedicineCell BiologyMolecular BiologyBiotechnology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy